These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 6439141

  • 1. Failure of chelation therapy in lead nephropathy.
    Germain MJ, Braden GL, Fitzgibbons JP.
    Arch Intern Med; 1984 Dec; 144(12):2419-20. PubMed ID: 6439141
    [Abstract] [Full Text] [Related]

  • 2. [Acute renal failure in the course of occupational lead intoxication. Chelation therapy responsability (author's transl)].
    Yver L, Maréchaud R, Picaud D, Touchard G, d'Eyzac AT, Matuchansky C, Patte D.
    Nouv Presse Med; 1978 May 06; 7(18):1541-3. PubMed ID: 97624
    [Abstract] [Full Text] [Related]

  • 3. Chelation therapy in lead nephropathy questioned.
    Sawyer HJ.
    Arch Intern Med; 1985 Oct 06; 145(10):1927. PubMed ID: 3929710
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Detection and treatment of occupational lead nephropathy.
    Wedeen RP, Malik DK, Batuman V.
    Arch Intern Med; 1979 Jan 06; 139(1):53-7. PubMed ID: 760684
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Case of lead nephropathy due to chronic occupational lead exposure].
    Ogata A, Sueta S, Tagawa M.
    Nihon Jinzo Gakkai Shi; 2011 Jan 06; 53(2):207-11. PubMed ID: 21516708
    [Abstract] [Full Text] [Related]

  • 12. Effect of zinc supplementation during chelation therapy in plumbism: a case report.
    Finelli VN, Lerner S, Hong C, Lohiya G.
    Med Lav; 1980 Jan 06; 71(2):149-56. PubMed ID: 6780775
    [No Abstract] [Full Text] [Related]

  • 13. Zinc supplementation of chelation therapy in saturnism. Preliminary study.
    Bădulici S, Chirilă M.
    Rom J Intern Med; 1992 Jan 06; 30(3):211-5. PubMed ID: 1475600
    [Abstract] [Full Text] [Related]

  • 14. Increased body lead burden--cause or consequence of chronic renal insufficiency?
    Marsden PA.
    N Engl J Med; 2003 Jan 23; 348(4):345-7. PubMed ID: 12540649
    [No Abstract] [Full Text] [Related]

  • 15. Occult lead intoxication in patients with gout and kidney disease.
    Wright LF, Saylor RP, Cecere FA.
    J Rheumatol; 1984 Aug 23; 11(4):517-20. PubMed ID: 6434739
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT, Lin JL, Yen TH, Chen KH, Huang YL.
    Nephrol Dial Transplant; 2007 Oct 23; 22(10):2924-31. PubMed ID: 17556414
    [Abstract] [Full Text] [Related]

  • 17. Lead and the kidney: nephropathy, hypertension, and gout.
    Perazella MA.
    Conn Med; 1996 Sep 23; 60(9):521-6. PubMed ID: 8908777
    [Abstract] [Full Text] [Related]

  • 18. Lead, mercury and cadmium nephropathy.
    Wedeen RP.
    Neurotoxicology; 1983 Sep 23; 4(3):134-46. PubMed ID: 6419181
    [No Abstract] [Full Text] [Related]

  • 19. [Chronic lead poisoning: Lead gout with giant tophi on the skin, nephrophathy and porphyrinopathy].
    Orfanos CE, Künzig M.
    Hautarzt; 1975 Nov 23; 26(11):581-4. PubMed ID: 812845
    [Abstract] [Full Text] [Related]

  • 20. [Does lead cause renal damage? Surprising results published in a respected journal].
    Elinder CG.
    Lakartidningen; 2003 May 08; 100(19):1736. PubMed ID: 12800302
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.